AI assistant
Nath Biogene India Ltd. — Call Transcript 2025
Nov 10, 2025
63545_rns_2025-11-10_1d69fdc4-fb5e-4165-b4d2-d8f43d6433f6.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [177 x 81] intentionally omitted <==
10[th] November 2025
The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051
BSE Code-537291 NSE Code-NATHBIOGEN
Dear Sirs,
Subject- Intimation of Earning Conference Call.
This is to inform that the Company will hold Earning Conference Call on Friday, 14[th] November 2025 at 12:30 PM IST.
Please find attached herewith the Conference Call Dial in Information.
Thanking You
For Nath Bio-Genes (India) Limited
Digitally signed by Amol Arunrao Amol Arunrao Gupta Gupta Date: 2025.11.10 15:26:17 +05'30' Amol Gupta Chief Financial Officer
==> picture [425 x 136] intentionally omitted <==
==> picture [426 x 34] intentionally omitted <==
==> picture [101 x 56] intentionally omitted <==
==> picture [75 x 51] intentionally omitted <==
Nath Bio-Genes (I) Limited
Q2 & H1FY26 Earnings Conference Call
Hosted by Go India Advisors
On Friday, November 14, 2025
12:30 PM IST
Company Participants
Mr. Satish Kagliwal Managing Director Dr. Devinder Khurana Executive Vice President
Mr. Amol Gupta Chief Financial Officer
Mr. Harish Pandey Sales Lead Mr. Venkatesh Kulkarni Research Lead
Call in Details:
Pre-register to avoid wait time, join with Diamond Pass.
Registration link: CLICK HERE
Dial in Numbers: Please dial-in at least 5-10 minutes prior to the conference call schedule to ensure that you are connected to the call on time
Universal Dial-In Number +91 22 6280 1557/ +91 22 7115 8383
For further information, kindly contact:
Deepika Sharma [email protected]
Sheetal Khanduja [email protected]